Taylor Daphne
Insider CIK 1393549 · APVO SVP, CFO · BLFS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 638 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 638 | — | $0 | 638 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 638 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 638 | — | — | 638 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 11,500 | — | $0 | 11,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 3 | — | $0 | 8 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 3 | — | $0 | 3 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-04 | 2025-03-04 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-04 | 2025-03-04 | 1 | — | $0 | 18 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-02 | 2025-03-04 | 2 | — | $0 | 2 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-02 | 2025-03-04 | 2 | — | $0 | 17 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-08-08 | 2024-08-09 | 158 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-08-08 | 2024-08-09 | 158 | — | $0 | 576 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 8,550 | — | $0 | 8,550 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-04 | 2024-03-05 | 1,584 | — | $0 | 1,583 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-04 | 2024-03-05 | 1,584 | — | $0 | 18,411 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-02 | 2024-03-05 | 3,667 | — | $0 | 7,333 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-02 | 2024-03-05 | 3,667 | — | $0 | 16,827 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-01-29 | 2024-01-30 | 792 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-01-29 | 2024-01-30 | 792 | — | $0 | 13,160 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-08 | 2023-08-10 | 6,945 | — | $0 | 6,944 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-08 | 2023-08-10 | 6,945 | — | $0 | 12,368 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-03-04 | 2023-03-07 | 1,583 | — | $0 | 3,167 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-03-04 | 2023-03-07 | 1,583 | — | $0 | 5,423 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 11,000 | — | $0 | 11,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 11,000 | — | $0 | 11,000 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award deriv | 2015-05-04 | 2015-05-06 | 174,510 | — | $0 | 174,510 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award deriv | 2012-02-15 | 2012-02-17 | 250,000 | — | $0 | 1,000,000 | SEC↗ |